We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Obesity Is Unreliable Predictor of Heart Disease

By HospiMedica staff writers
Posted on 18 Sep 2006
A new study shows that body mass index (BMI), a commonly used measure of obesity, cannot reliably predict the outcome for patients with heart disease.

Researchers from the Mayo Clinic College of Medicine (Rochester, MN, USA) combined data from 40 studies to determine the association between obesity and total mortality and cardiovascular events in patients with coronary artery disease (CAD). More...
The studies involved a total of about 250,000 obese people with CAD, with an average follow-up of four years. Most of the studies used BMI as a measure of obesity. The investigators found that patients with a low BMI had a higher risk of death than those with a normal BMI.

Overweight patients had better survival and fewer heart problems than those with a normal BMI. Obese people who had had bypass surgery had a higher death rate when compared with people with a normal BMI, while severely obese people had a higher risk of a heart-related death, but not death from other causes. The results were published in the August 19, 2006, edition of The Lancet.

The better outcomes for overweight people may be because they have more muscle than normal weight people, stated the authors. The results therefore demonstrate the inability of BMI to discriminate between body fat and lean muscle, they conclude.

"Rather than proving that obesity is harmless, our data suggest that alternative methods might be needed to better characterize individuals who truly have excess body fat, compared with those in whom BMI is raised because of preserved muscle mass,” said lead author Dr. Francisco Lopez- Jimenez, of the division of cardiovascular diseases at the Mayo Clinic.

Body Mass Index is a measure of relative heaviness/obesity, reached by dividing a person's body weight in kilograms by the height in meters squared. The healthy BMI range is between 18.5 and 24.9. A BMI between 25 and 29 is considered overweight, and a BMI over 30 is considered obese. Because it considers both weight and height, it is usually the measure most often used in research for referring to relative sizes.



Related Links:
Mayo Clinic College of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.